Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Blood|August 12, 2022
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidineHartmut Döhner, Andrew H Wei, Gail J Roboz, et al.
Leukemia|April 11, 2019
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemiaDaniel A Pollyea, Martin S Tallman, Stéphane de Botton, et al.
The Lancet. Haematology|March 9, 2020
Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trialEytan M Stein, Amir T Fathi, Courtney D DiNardo, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
Atomically accurate de novo design of antibodies with RFdiffusionNathaniel R Bennett, Joseph L Watson, Robert J Ragotte, et al.
Nature|November 5, 2025
Atomically accurate de novo design of antibodies with RFdiffusionNathaniel R Bennett, Joseph L Watson, Robert J Ragotte, et al.
Pageof 6